Phio Pharmaceuticals Corp.
REDUCED SIZE SELF-DELIVERING RNAI COMPOUNDS
Last updated:
Abstract:
The present invention relates to methods for in vivo administration of sd-rxRNA molecules.
Status:
Application
Type:
Utility
Filling date:
7 Feb 2019
Issue date:
2 Jan 2020